Literature DB >> 9494864

Magnetic resonance spectroscopy in vivo: applications in neurological disorders.

D L Arnold1, N De Stefano.   

Abstract

Magnetic resonance (MR) spectroscopy (MRS) is performed using the same magnets and computers as conventional MR imaging (MRI). However, unlike conventional MRI, which provides structural information, MRS provides chemical information that represents pathologically specific measures useful for diagnosis and monitoring of patients affected by neurological disorders. This review will focus on selected clinical applications of MRS that have been demonstrated to have clinical use. These include phosphorus MRS of muscle to diagnose metabolic muscle disease, and proton MRS of brain to lateralize temporal lobe epilepsy, to classify brain tumors, and to evaluate the natural history and pathology of multiple sclerosis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9494864     DOI: 10.1007/BF02048235

Source DB:  PubMed          Journal:  Ital J Neurol Sci        ISSN: 0392-0461


  44 in total

Review 1.  Clinical tools for the 90s: magnetic resonance spectroscopy and metabolite imaging.

Authors:  B Ross; R Kreis; T Ernst
Journal:  Eur J Radiol       Date:  1992 Mar-Apr       Impact factor: 3.528

2.  Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis.

Authors:  P M Matthews; G Francis; J Antel; D L Arnold
Journal:  Neurology       Date:  1991-08       Impact factor: 9.910

3.  Progressive cerebral atrophy in multiple sclerosis. A serial MRI study.

Authors:  N A Losseff; L Wang; H M Lai; D S Yoo; M L Gawne-Cain; W I McDonald; D H Miller; A J Thompson
Journal:  Brain       Date:  1996-12       Impact factor: 13.501

4.  A proton magnetic resonance spectroscopy study of focal epilepsy in humans.

Authors:  P M Matthews; F Andermann; D L Arnold
Journal:  Neurology       Date:  1990-06       Impact factor: 9.910

5.  Detection of hippocampal pathology in intractable partial epilepsy: increased sensitivity with quantitative magnetic resonance T2 relaxometry.

Authors:  G D Jackson; A Connelly; J S Duncan; R A Grünewald; D G Gadian
Journal:  Neurology       Date:  1993-09       Impact factor: 9.910

6.  Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

Authors:  D H Miller; P S Albert; F Barkhof; G Francis; J A Frank; S Hodgkinson; F D Lublin; D W Paty; S C Reingold; J Simon
Journal:  Ann Neurol       Date:  1996-01       Impact factor: 10.422

Review 7.  Rachelle Fishman-Matthew Moore Lecture. The pathological and clinical dynamics of multiple sclerosis.

Authors:  W I McDonald
Journal:  J Neuropathol Exp Neurol       Date:  1994-07       Impact factor: 3.685

8.  Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.

Authors:  D L Arnold; P M Matthews; G S Francis; J O'Connor; J P Antel
Journal:  Ann Neurol       Date:  1992-03       Impact factor: 10.422

9.  Lateralization of temporal lobe epilepsy based on regional metabolic abnormalities in proton magnetic resonance spectroscopic images.

Authors:  F Cendes; F Andermann; M C Preul; D L Arnold
Journal:  Ann Neurol       Date:  1994-02       Impact factor: 10.422

10.  Imaging of axonal damage in vivo in Rasmussen's syndrome.

Authors:  F Cendes; F Andermann; K Silver; D L Arnold
Journal:  Brain       Date:  1995-06       Impact factor: 13.501

View more
  5 in total

Review 1.  Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer.

Authors:  J Kurhanewicz; D B Vigneron; S J Nelson
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  New perspectives in clinical neurology: the promise of non-conventional magnetic resonance techniques.

Authors:  A Federico; N De Stefano
Journal:  Ital J Neurol Sci       Date:  1997-12

3.  Multiproject-multicenter evaluation of automatic brain tumor classification by magnetic resonance spectroscopy.

Authors:  Juan M García-Gómez; Jan Luts; Margarida Julià-Sapé; Patrick Krooshof; Salvador Tortajada; Javier Vicente Robledo; Willem Melssen; Elies Fuster-García; Iván Olier; Geert Postma; Daniel Monleón; Angel Moreno-Torres; Jesús Pujol; Ana-Paula Candiota; M Carmen Martínez-Bisbal; Johan Suykens; Lutgarde Buydens; Bernardo Celda; Sabine Van Huffel; Carles Arús; Montserrat Robles
Journal:  MAGMA       Date:  2008-11-07       Impact factor: 2.310

4.  Cognitive deficits and magnetic resonance spectroscopy in adult monozygotic twins with lead poisoning.

Authors:  Marc G Weisskopf; Howard Hu; Robert V Mulkern; Roberta White; Antonio Aro; Steve Oliveira; Robert O Wright
Journal:  Environ Health Perspect       Date:  2004-04       Impact factor: 9.031

5.  Comparison of human brain metabolite levels using 1H MRS at 1.5T and 3.0T.

Authors:  Fernando Fernandes Paiva; Maria Concepcion Garcia Otaduy; Ricardo de Oliveira-Souza; Jorge Moll; Ivanei Edson Bramati; Luciane Oliveira; Andrea Silveira de Souza; Fernanda Tovar-Moll
Journal:  Dement Neuropsychol       Date:  2013 Apr-Jun
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.